Pharmacist Portal Dispense an ePrescription
Vivus announced that it has completed its phase III human studies for its erectile dysfunction treatment, Avanafil...
Regular use of painkillers has been reported to be potentially linked to erectile dysfunction (ED)...
California based pharmaceutical development company, Vivus, will have a busy month this January as they hope make progress with the FDA on their two leading drug candidates...
It was announced yesterday that late stage studies went well for Vivus’ hopeful erectile dysfunction treatment, Avanafil...
Canadian sufferers of erectile dysfunction will soon have another option for treating their condition in the form of a gel called Vitaros...